Gene Therapy

Investigators identify an eye cancer culprit

A team of investigators have found that a molecular mechanism that drives the progression of uveal melanoma, an often lethal eye cancer in adults.

Companies announce eye care collaboration

AbbVie and REGENXBIO announced a strategic partnership to develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases.

Optogenetic therapy: Gene-independent therapeutic strategies for retinal degeneration

José-Alain Sahel, MD, explains how optogenetics involves artificial photoreceptors from specific retinal cells to restore vision.

Study finds lasting immunity and protection from COVID-19 by single-shot, room-temperature, stable vaccine

September 09, 2021

The gene-based AAVCOVID vaccine employs a unique adeno-associated viral vector technology that was shown in non-clinical, nonhuman primate studies to enable protection from SARS-CoV-2 challenge and to induce sustained antibody and cellular immune responses from a single dose for up to a year.